Review highlights recent patents and technological innovations in osmotic drug delivery systems, suggesting improvements in patient compliance.
This review highlights the potential of osmotic-controlled drug delivery systems to improve therapeutic outcomes and patient compliance by enabling sustained and controlled drug release. Key formulation components and recent technological innovations, including patents, are highlighted for their role in enhancing system performance and guiding future pharmaceutical development.
No takes yet. Share an insight, caveat, or question.
Tiwari et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: